ESTRO 36 Programme book and exhibition guide

> Stereotactic robotic body radiotherapy for patients with pulmonary oligometastases P. Berkovic (Belgium), A. Gulyban, L. Swenen, D. Dechambre, P. Viet Nguyen, N. Jansen, C. Mievis, N. Bartelemy, P. Lovinfosse, M. Baré, F. Lakosi, L. Janvary, P.A. Coucke > Neutrophil-lymphocyte ratio and a dosimetric factor for symptomatic radiation pneumonitis in NSCLC Y.H. Lee, H.S. Choi, H. Jeong, K.M. Kang (Republic of Korea), J.H. Song, W.S. Lee, G.W. Lee, H.N. Song, H.G. Kim, M.H. Kang, D.Y. Rhee, B.K. Jeong > UK NCRI CTRad consensus on drug and radiotherapy combination platform studies in NSCLC G. Hanna (UK), F. McDonald, A. Greystoke, M. Forester, S. Brown, E. Hall, C. Faivre-Finn, S. Harrow, M. Hatton, A. Chalmers > Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC) O. Hansen (Denmark), M. Knap, A. Khalil, C. Nyhus, C. Brink, L. Hoffmann, T. Schytte > Post-operative radiotherapy (PORT) in patients with resected non small cell lung cancer (NSCLC) T. Schimek-Jasch (Germany), M. Kuppler, S. Adebahr, A.L. Grosu, U. Nestle > Early Clinical outcome of the first lung SBRT program in a developing country S. Wadi-Ramahi, J. Khader (Jordan), F. Abu Hijli, H. Ghatasheh, A. Sulaiman > Patient-reported toxicity in twice-daily (BID) versus once-daily (OD) chemoradiotherapy for LS-SCLC J. Lodeweges (The Netherlands), A. Niezink, H. Elzinga, E. Haan-Stijntjes, N. Dollekamp, O. Chouvalova, J. Ubbels, M. Woltman-van Iersel, A. Van der Leest, J. Langendijk, J. Widder > Early results of SBRT as a salvage treatment after thoracic radiotherapy. A. Navarro-Martin (Spain), I. Guix, J. Mases, M. Mutto, E. Nadal, F. Guedea

ELECTRONIC POSTERS

EP-1226

EP-1227

EP-1228

EP-1229

EP-1230

EP-1231

EP-1232

EP-1233

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

244